Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Applications of nanoparticles in the detection and treatment of kidney diseases.

Literature DB >> 24206598

Applications of nanoparticles in the detection and treatment of kidney diseases.

Abstract

Nanoparticles have emerged in the medical field as a technology well suited for the diagnosis and treatment of various disease states. They have been heralded as efficacious in terms of improved therapeutic efficacy and reduction of treatment side effects in some cases. Various nanomaterials have been developed that can be tagged with targeting moieties as well as with drug delivery and imaging capability or a combination of both as a theranostic agent. These nanomaterials have been investigated for treatment and detection of various pathological conditions. The emphasis of this review is to demonstrate current research and clinical applications for nanoparticles in the diagnosis and treatment of kidney diseases.

Entities: Chemical Disease Gene Mutation Species

Keywords: Kidney disease; Nanoparticles; Review; Targeting; Treatment

Mesh：

Year: 2013 PMID： 24206598 PMCID： PMC3824259 DOI： 10.1053/j.ackd.2013.07.006

Source DB: PubMed Journal: Adv Chronic Kidney Dis ISSN： 1548-5595 Impact factor: 3.620

114 in total

1. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors: Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal: Circ Res Date: 2000-11-24 Impact factor: 17.367

2. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression.

Authors: Ophir Marom; Farid Nakhoul; Ulrike Tisch; Ala Shiban; Zaid Abassi; Hossam Haick
Journal: Nanomedicine (Lond) Date: 2012-03-08 Impact factor: 5.307

Review 3. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art.

Authors: Jagdish L Italia; Vivekanand Bhardwaj; M N V Ravi Kumar
Journal: Drug Discov Today Date: 2006-09 Impact factor: 7.851

4. Coenzyme Q10 in essential hypertension.

Authors: V Digiesi; F Cantini; A Oradei; G Bisi; G C Guarino; A Brocchi; F Bellandi; M Mancini; G P Littarru
Journal: Mol Aspects Med Date: 1994

5. Toxicity evaluation of hydrophilic CdTe quantum dots and CdTe@SiO2 nanoparticles in mice.

Authors: Asma Sadaf; Basit Zeshan; Zhuyuan Wang; Ruohu Zhang; Shuhong Xu; Chunlei Wang; Yiping Cui
Journal: J Nanosci Nanotechnol Date: 2012-11

6. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice.

Authors: Christoph Bremer; Mona Mustafa; Alex Bogdanov; Vasilis Ntziachristos; Alexander Petrovsky; Ralph Weissleder
Journal: Radiology Date: 2003-01 Impact factor: 11.105

7. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors: W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal: Circ Res Date: 1996-03 Impact factor: 17.367

8. Thermoablation of malignant kidney tumors using magnetic nanoparticles: an in vivo feasibility study in a rabbit model.

Authors: Philipp Bruners; Till Braunschweig; Michael Hodenius; Hubertus Pietsch; Tobias Penzkofer; Martin Baumann; Rolf W Günther; Thomas Schmitz-Rode; Andreas H Mahnken
Journal: Cardiovasc Intervent Radiol Date: 2009-05-09 Impact factor: 2.740

Review 9. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors: Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal: Mol Pharm Date: 2009 Sep-Oct Impact factor: 4.939

10. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury.

Authors: Maram K Reddy; Vinod Labhasetwar
Journal: FASEB J Date: 2009-01-05 Impact factor: 5.191

13 in total

1. Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.

Authors: Aniruddha Roy; Yucheng Zhao; Yang Yang; Andras Szeitz; Tara Klassen; Shyh-Dar Li
Journal: Biomaterials Date: 2017-05-11 Impact factor: 12.479

Applications of nanoparticles in the detection and treatment of kidney diseases.

1. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

2. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression.

Review 3. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art.

4. Coenzyme Q10 in essential hypertension.

5. Toxicity evaluation of hydrophilic CdTe quantum dots and CdTe@SiO2 nanoparticles in mice.

6. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice.

7. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

8. Thermoablation of malignant kidney tumors using magnetic nanoparticles: an in vivo feasibility study in a rabbit model.

Review 9. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

10. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury.

1. Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.

2. Magnetic Iron Oxide Nanoparticles for Biomedical Applications.

Review 3. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases.

Review 4. pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

5. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Review 6. Light-Emitting Agents for Noninvasive Assessment of Kidney Function.

Review 7. Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.

Review 8. A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

Review 9. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases.

Review 10. Pharmaceutical nanotechnology: from the bench to the market.